Andrew J. Hillman

Dallas-based biotech executive, FDA regulatory strategist, and expert witness in healthcare compliance. Thirty years co-founding and advising FDA-regulated ventures spanning biologics, orthopedics, pharmacy, surgical hospitals, and clinical labs.

Current focus: 351(a) BLA pathway strategy for regenerative medicine biologics and expert witness practice in healthcare compliance disputes (Anti-Kickback Statute, Stark Law, HIPAA, OIG).

Founder of the Andrew Hillman Scholarship for Entrepreneurs and Andrew Hillman Grant for Biotech. Board service at Texas Scottish Rite Hospital for Children. Based in Dallas, Texas. Practicing since 1995.

Full profile: andrewjhillman.com